1. A novel model based on necroptosis-related genes for predicting immune status and prognosis in glioma
    Ying-Shi Yuan et al, 2022, Frontiers in Immunology CrossRef
  2. PI3K Signaling Pathways as a Molecular Target for Glioblastoma Multiforme
    Andressa Letícia Lopes da Silva et al, 2024, Current Protein & Peptide Science CrossRef
  3. Proton pump inhibitors display anti‐tumour potential in glioma
    Bihan Li et al, 2023, Cell Proliferation CrossRef
  4. Long-acting therapeutic delivery systems for the treatment of gliomas
    Smrithi Padmakumar et al, 2023, Advanced Drug Delivery Reviews CrossRef
  5. The genetic algorithm-aided three-stage ensemble learning method identified a robust survival risk score in patients with glioma
    Sujie Zhu et al, 2022, Briefings in Bioinformatics CrossRef
  6. Unveiling the anti-glioma potential of a marine derivative, Fucoidan: its synergistic cytotoxicity with Temozolomide—an in vitro and in silico experimental study
    Indrani Biswas et al, 2023, 3 Biotech CrossRef
  7. The role of lysosomal peptidases in glioma immune escape: underlying mechanisms and therapeutic strategies
    Hao Liu et al, 2023, Frontiers in Immunology CrossRef
  8. Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy
    Tatiana A. Mishchenko et al, 2024, Frontiers in Immunology CrossRef
  9. The Temozolomide–Doxorubicin paradox in Glioblastoma in vitro–in silico preclinical drug-screening
    Mariam-Eleni Oraiopoulou et al, 2024, Scientific Reports CrossRef
  10. Iron oxide nanoparticles induce ferroptosis via the autophagic pathway by synergistic bundling with paclitaxel
    Qi Nie et al, 2023, Molecular Medicine Reports CrossRef
  11. Tumor-Derived Membrane Vesicles Restrain Migration in Gliomas By Altering Collective Polarization
    Megha Jhunjhunwala et al, 2023, ACS Applied Bio Materials CrossRef
  12. Forkhead box transcription factors (FOXOs and FOXM1) in glioma: from molecular mechanisms to therapeutics
    Peyman Tabnak et al, 2023, Cancer Cell International CrossRef